Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ORTHOPEDIATRICS CORPKIDS · Entity 5338 | Director | June 01, 2022 | June 03, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ORTHOPEDIATRICS CORP
Report date June 01, 2022 · Filed June 03, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,291 |
Reported balance
After 2022-06-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-06-01 · Grant · Acquired 1,691 · Balance 7,291 F1: Includes restricted stock awards totaling 3,092 shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes restricted stock awards totaling 3,092 shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2022 Filed Jun 3, 2022 08:13 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GrantCommon Stock | 1,691 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-22-000066 · wf-form4_165425839790261.xml · nonDerivative · entry 1 Unger Kevin · CIK 0001478366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,291 F1 · balance_after: Includes restricted stock awards totaling 3,092 shares. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 14:31 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GrantCommon Stock | 1,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-21-000101 · wf-form4_162283147629320.xml · nonDerivative · entry 1 Unger Kevin · CIK 0001478366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,600 F1 · balance_after: Includes restricted stock awards totaling 2,801 shares. Read SEC document |
| June 03, 2020 Filed Jun 4, 2020 15:34 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GrantCommon Stock | 1,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-20-000078 · wf-form4_159129927914490.xml · nonDerivative · entry 1 Unger Kevin · CIK 0001478366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,200 F1 · balance_after: Includes restricted stock awards totaling 2,801 shares. Read SEC document |
| June 05, 2019 Filed Jun 7, 2019 15:08 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GrantCommon Stock | 1,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-19-000071 · wf-form4_155993449962230.xml · nonDerivative · entry 1 Unger Kevin · CIK 0001478366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,800 F1 · balance_after: Includes restricted stock awards totaling 2,334 shares. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 14:08 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | Exercise / conversionStock Option (Right to Buy) · Derivative | 196 | $30.97 Strike: $30.97 | $6,070.12 |
DisclosureSEC source: 0001425450-18-000108 · wf-form4_153694848736412.xml · derivative · entry 3 Unger Kevin · CIK 0001478366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 474 Underlying: Common Stock · 196 shares Expires 2023-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option is fully vested and immediately exercisable. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 14:08 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 1,000 | $33.22 | $33,220.00 |
DisclosureSEC source: 0001425450-18-000108 · wf-form4_153694848736412.xml · nonDerivative · entry 2 Unger Kevin · CIK 0001478366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,400 F1 · balance_after: Includes restricted stock awards totaling 1,400 shares subject to vesting requirements. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 14:08 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | Exercise / conversionCommon Stock | 196 | $30.97 | $6,070.12 |
DisclosureSEC source: 0001425450-18-000108 · wf-form4_153694848736412.xml · nonDerivative · entry 1 Unger Kevin · CIK 0001478366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 20, 2018 Filed Jun 22, 2018 17:02 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GrantCommon Stock | 1,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-18-000088 · wf-form4_152970130948542.xml · nonDerivative · entry 1 Unger Kevin · CIK 0001478366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,204 F1 · balance_after: Includes restricted stock awards totaling 1,400 shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.